Figure 2.

VRK2 and astrocytoma survival. Kaplan-Meier estimates of overall survival in (A) low-grade astrocytomas and (B) high-grade astrocytomas according to VRK2 protein expression. (C). Kaplan-Meier estimates of overall survival for low-risk and high-risk groups, based on the prognostic index combining VRK2 protein level, age and treatment (Table 6) in cases of high-grade astrocytomas.

Rodríguez-Hernández et al. BMC Clinical Pathology 2013 13:23   doi:10.1186/1472-6890-13-23
Download authors' original image